Oxford Cancer Analytics
PrivateLast Round
Series A
Jan 9, 2025
Total Funding Raised
$16.46M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Oxford Cancer Analytics operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Series A round in January 2025.
Oxford Cancer Analytics is a healthtech company that develops liquid biopsy blood tests using advanced proteomics and artificial intelligence for the early detection of lung cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Cancer Analytics Comparables
Compare Oxford Cancer Analytics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PrognomiQ | 86% | |
| Delfi Diagnostics | 85% | |
| Averywell | 82% |
For institutional investors. Book with your work email.
Oxford Cancer Analytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 9, 2025 | ||||
| Seed | Jan 9, 2023 | ||||
| Seed | Sep 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oxford Cancer Analytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OKG Capital | Series A |
| We Venture Capital | Series A |
| Cancer Research UK | Seed |
| The Francis Crick Institute | Seed |
| Cross Border Impact Ventures | Series A |
| DigitalDx Ventures | Series A |
| LifeArc | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 56% MoM.
- Jul 26, 2026
Monthly visitors grew 437% MoM, from 371 to 2K.
For institutional investors. Book with your work email.
Oxford Cancer Analytics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oxford Cancer Analytics's valuation, stock price, and market status.
Is Oxford Cancer Analytics a public or private company?
Oxford Cancer Analytics is a private company.
What is the current stock price of Oxford Cancer Analytics?
Oxford Cancer Analytics is a private company, so its shares have no public market price. Caplight tracks Oxford Cancer Analytics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oxford Cancer Analytics worth (valuation)?
Valuation information for Oxford Cancer Analytics is not publicly available.
Can I buy Oxford Cancer Analytics stock?
Oxford Cancer Analytics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oxford Cancer Analytics's last funding round?
Oxford Cancer Analytics's most recent funding round was Series A on January 9, 2025.
Who are the main investors in Oxford Cancer Analytics?
Key investors in Oxford Cancer Analytics include We Venture Capital, Cross Border Impact Ventures, 青創同行 We Venture, Eka Ventures.
Will Oxford Cancer Analytics IPO soon?
No public IPO plans have been announced for Oxford Cancer Analytics.
How can I track Oxford Cancer Analytics secondary market activity?
Caplight tracks bids, offers, and trades in Oxford Cancer Analytics's shares on secondary markets.